经 mRNA-LNP 平台靶向递送 IFN-α-抗 GPC3 融合蛋白在肝细胞癌中激发强效抗肿瘤免疫
Targeted delivery of IFN-α-anti-GPC3 fusion protein via mRNA-LNP platform elicits potent anti-tumor immunity in hepatocellular carcinoma.
55.5分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Targeted delivery of IFN-α-anti-GPC3 fusion protein via mRNA-LNP platform elicits potent anti-tumor immunity in hepatocellular carcinoma.
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy.
GPC3 是 HCC 免疫治疗的理想肿瘤抗原。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。